Ability To Make Prompt Payment. Neither the Company nor any of its subsidiaries shall enter into any agreement that would restrict the Company’s right to be able to promptly make or cause to be made payments to the Holders under this Agreement or otherwise restrict the Company’s ability to fund or cause to be funded such payments.
Appears in 6 contracts
Samples: Contingent Cash Consideration Agreement (Endo Pharmaceuticals Holdings Inc), Contingent Cash Consideration Agreement (Indevus Pharmaceuticals Inc), Contingent Cash Consideration Agreement (Endo Pharmaceuticals Holdings Inc)
Ability To Make Prompt Payment. Neither the Company nor any of its subsidiaries shall enter into any agreement that would restrict the Company’s right obligation or ability to be able to promptly make or cause to be made payments to the Holders under this Agreement or otherwise restrict the Company’s ability to fund or cause to be funded such payments.
Appears in 3 contracts
Samples: Contingent Cash Consideration Agreement (Teva Pharmaceutical Industries LTD), Contingent Cash Consideration Agreement (Nupathe Inc.), Contingent Cash Consideration Agreement (Nupathe Inc.)
Ability To Make Prompt Payment. Neither the The Company nor any of its subsidiaries shall not enter into any agreement that would restrict the Company’s right to be able to promptly make or cause to be made payments to the Holders under this Agreement or otherwise restrict the Company’s ability to fund or cause to be funded such payments.
Appears in 2 contracts
Samples: Contingent Value Rights Agreement (EPIX Pharmaceuticals, Inc.), Contingent Value Rights Agreement (EPIX Pharmaceuticals, Inc.)
